US-headquartered cleantech advanced materials company DetraPel has raised $7.6m in Series A funding round led by Material Impact.
Packaging ink manufacturer INX International, along with Touchdown Ventures, FitzGate Ventures, Boro Capital, Icebook Investments and others also joined the financing round.
DetraPel will leverage the proceeds from the funding to further build the momentum gained by its recently rebranded industrial arm, Impermea Materials, in the market. It will help address the growing demand for protective coatings in manufacturing.
Impermea Materials has been supplying patented protective coatings made from perfluoroalkyl and polyfluoroalkyl substances (PFAS)-free and Fluorine-free, bio-based chemistries to paper and paperboard packaging, textiles and healthcare industries.
The funds will scale up Impermea Materials’ production processes, which include product development that is currently in progress, a new advanced synthesis laboratory, an application and commercialisation laboratory, sales, marketing, and more.
DetraPel, which specialises in synthesising and manufacturing PFAS-free protective coatings, serves four major paper suppliers and consumer packaged goods companies across the globe.
DetraPel founder and CEO David Zamarin said: "Since our inception a decade ago, we have been developing PFAS-free (100% fluorine-free), water-based chemistries that outperform their fluorinated counterparts. Our team is now at the forefront of the industrial manufacturing transition currently underway to remove toxic chemicals from the everyday products we come into contact with.
"For brands looking to accelerate the transition to safer solutions and match performance goals, our team at Impermea works directly with manufacturing teams to remove the chemicals and plastics without sacrificing the everyday performance of the products and creating new efficiencies across their supply chain."
